Xie P - Search Results

1

Abplatin^(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin.

Li X, Zhang L, Li T, Li S, Wu W, Zhao L, Xie P, Yang J, Li P, Zhang Y, Xiao H, Yu Y, Zhao Z. Li X, et al. Among authors: xie p. J Nanobiotechnology. 2022 Jun 3;20(1):258. doi: 10.1186/s12951-022-01465-y. J Nanobiotechnology. 2022. PMID: 35659243 Free PMC article.

2

Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance.

Xie P, Wang Y, Wei D, Zhang L, Zhang B, Xiao H, Song H, Mao X. Xie P, et al. J Mater Chem B. 2021 Jul 7;9(26):5173-5194. doi: 10.1039/d1tb00753j. J Mater Chem B. 2021. PMID: 34116565 Review.

3

Nanoparticle delivery of a triple-action Pt(IV) prodrug to overcome cisplatin resistance via synergistic effect.

Xie P, Jin Q, Li Y, Zhang J, Kang X, Zhu J, Mao X, Cao P, Liu C. Xie P, et al. Biomater Sci. 2021 Dec 21;10(1):153-157. doi: 10.1039/d1bm01556g. Biomater Sci. 2021. PMID: 34811566

4

Photothermal Therapy via NIR II Light Irradiation Enhances DNA Damage and Endoplasmic Reticulum Stress for Efficient Chemotherapy.

Kong Q, Wei D, Xie P, Wang B, Yu K, Kang X, Wang Y. Kong Q, et al. Among authors: xie p. Front Pharmacol. 2021 Apr 29;12:670207. doi: 10.3389/fphar.2021.670207. eCollection 2021. Front Pharmacol. 2021. PMID: 33995101 Free PMC article.

5

Gypenoside LI arrests the cell cycle of breast cancer in G0/G1 phase by down-regulating E2F1.

Zu ML, Duan Y, Xie JB, Qi YS, Xie P, Borjigidai A, Piao XL. Zu ML, et al. Among authors: xie p, xie jb. J Ethnopharmacol. 2021 Jun 12;273:114017. doi: 10.1016/j.jep.2021.114017. Epub 2021 Mar 11. J Ethnopharmacol. 2021. PMID: 33716078

6

Uncovering the anti-NSCLC effects and mechanisms of gypenosides by metabolomics and network pharmacology analysis.

Qi YS, Xie JB, Xie P, Duan Y, Ling YQ, Gu YL, Piao XL. Qi YS, et al. Among authors: xie p, xie jb. J Ethnopharmacol. 2021 Dec 5;281:114506. doi: 10.1016/j.jep.2021.114506. Epub 2021 Aug 6. J Ethnopharmacol. 2021. PMID: 34371113

7

Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response.

Xiao MY, Pei WJ, Li S, Li FF, Xie P, Luo HT, Hyun Yoo H, Piao XL. Xiao MY, et al. Among authors: xie p. Bioorg Chem. 2024 Sep;150:107539. doi: 10.1016/j.bioorg.2024.107539. Epub 2024 Jun 8. Bioorg Chem. 2024. PMID: 38861912

8

Gypenosides suppress hepatocellular carcinoma cells by blocking cholesterol biosynthesis through inhibition of MVA pathway enzyme HMGCS1.

Xiao MY, Li FF, Xie P, Qi YS, Xie JB, Pei WJ, Luo HT, Guo M, Gu YL, Piao XL. Xiao MY, et al. Among authors: xie p, xie jb. Chem Biol Interact. 2023 Sep 25;383:110674. doi: 10.1016/j.cbi.2023.110674. Epub 2023 Aug 19. Chem Biol Interact. 2023. PMID: 37604220

9

Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy.

Xie P, Guo M, Xie JB, Xiao MY, Qi YS, Duan Y, Li FF, Piao XL. Xie P, et al. Among authors: xie jb. J Ethnopharmacol. 2022 Aug 10;294:115335. doi: 10.1016/j.jep.2022.115335. Epub 2022 May 2. J Ethnopharmacol. 2022. PMID: 35513215

10

Saponins derived from Gynostemma pentaphyllum regulate triglyceride and cholesterol metabolism and the mechanisms: A review.

Xie P, Luo HT, Pei WJ, Xiao MY, Li FF, Gu YL, Piao XL. Xie P, et al. J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117186. doi: 10.1016/j.jep.2023.117186. Epub 2023 Sep 16. J Ethnopharmacol. 2024. PMID: 37722515 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,714 results

Search Page

Filters